Screening efficiency over experience: Rapid target detection in low‐power field as a modifiable cognitive biomarker for diagnostic accuracy in digital cytology
Jul 2026· Cancer Cytopathology· Vol 134· 0 citations· 43 references
Medicine
TL;DR
Cognitive biomarkers associated with diagnostic accuracy and their modifiability are identified and evaluated to identify and evaluate their modifiability.
Abstract
Traditionally, cytology expertise has been equated with professional experience. However, the transition to whole‐slide imaging and artificial intelligence (AI) necessitates a shift from exhaustive screening to rapid verification. The goal of this study was to identify cognitive biomarkers associated with diagnostic accuracy and evaluate their modifiability.
This article, from a Point/Counterpoint on implementation of artificial intelligence (AI) in breast imaging, argues that key issues must be addressed before wider adoption, including medicolegal ambiguities, impact on disparities, data drift, and scaling costs. More robust infrastructure and regulations will ultimate...
E. Langman, V. Loving· AJR. American journal of roe...· 0 citations
This article, from a Point/Counterpoint on implementation of artificial intelligence (AI) in breast imaging, argues that the available evidence, including prospective and real-world studies demonstrating clinical benefit, is sufficient to support clinical implementation of AI-supported mammography screening with appr...
M. Bahl· AJR. American journal of roe...· 0 citations
Introduction Breast cancer continues to threaten millions of women globally, and early detection is essential for saving lives. However, inconsistencies in radiological interpretation and uncertainty in lesion assessment limit diagnostic reliability. This study proposes FGOOPNet, a fuzzy deep ensemble model designed to...
Ho-Dat Tran, Anh-Cang Phan, Thuong-Cang Phan· Current medical imaging· 0 citations
Confirmatory prostate-specific antigen measurement reclassifies many younger men below the biopsy threshold, offering a simple, low-cost way to reduce magnetic resonance imaging and biopsy. For most, reclassification means deferral rather than exclusion, and follow-up remains insufficient to rule out missed clinically...
A. Rannikko, T. Kilpeläinen, Anssi Auvinen· European Urology· 0 citations
When this Special Issue opened in January 2024, its premise was straightforward but ambitious: imaging had moved well beyond a gatekeeping role ahead of biopsy, and the structural, functional, and metabolic data extracted from ultrasound, CT, MRI, and PET were becoming primary evidence in their own right, with artifici...
Giovanni Sussan, F. Crimì· Tomography· 0 citations
Artificial intelligence, noninvasive imaging, and molecular profiling are improving skin cancer assessment, but technological progress alone does not guarantee better care. The papers highlighted in this issue examine digital detection, advanced imaging, melanoma recognition, and molecular prognosis, emphasizing that p...
L. Kemény· International Journal of Der...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
